Calcific aortic valve disease: imaging studies and therapeutic interventions

Area of Science:

• Cardiology
• Medical Imaging
• Clinical Research

Background:

• Echocardiography is the primary noninvasive imaging tool for aortic valve disease due to its accuracy and reproducibility.
• Cardiac catheterization is reserved for unclear diagnoses, pre-valve replacement angiography, or complex cases.
• Cardiac CT quantifies aortic valve calcium (AVC), a marker in medical therapy trials.

Purpose of the Study:

• To review current imaging modalities for aortic valve disease.
• To summarize recent clinical trials on medical therapies for aortic valve disease progression.

Main Methods:

• Review of echocardiography, cardiac catheterization, and cardiac CT for aortic valve disease assessment.
• Analysis of retrospective and prospective randomized trials evaluating medical therapies.

Main Results:

• Retrospective studies suggest 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) may slow disease progression.
• Conflicting results emerged from recent prospective, randomized trials on statin efficacy.
• Data on angiotensin converting enzyme (ACE) inhibitors for aortic valve disease are still preliminary.

Conclusions:

• Imaging plays a crucial role in managing aortic valve disease.
• Medical therapy for aortic valve disease, particularly statins, requires further investigation due to conflicting trial data.
• Future research is needed to establish effective medical treatments to reduce aortic valve disease progression.